CAR T-Cell Production Using Nonviral Approaches

Chimeric antigen receptor T-cells (CAR T-cells) represent a novel and promising approach in cancer immunotherapy. According to the World Health Organization (WHO), the number of oncological patients is steadily growing in developed countries despite immense progress in oncological treatments, and th...

Descripción completa

Detalles Bibliográficos
Autores principales: Lukjanov, Viktor, Koutná, Irena, Šimara, Pavel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019376/
https://www.ncbi.nlm.nih.gov/pubmed/33855089
http://dx.doi.org/10.1155/2021/6644685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019376/
https://www.ncbi.nlm.nih.gov/pubmed/33855089
http://dx.doi.org/10.1155/2021/6644685

Ejemplares similares